that's my take also... I don't expect a COH deal/team
up with RAC (if that happens it's an extra bonus, on top of the original bonus which was COH doing research on Bisantrene in the first place and releasing a positive report).
COH research inherently increases the value proposition of RAC's IP (Bisantrene) and having one of the Rock Stars of cancer research (COH) to write good things about Bisantrene for free without RAC involvement, is like getting Michael Jordan to endorse your sneakers because he thinks it's the best product and not because you are paying him millions. The market is going to pay attention to Michael Jordon/ COH !!!
Just waiting on RAC/ Dr T to formally review the research report and announce to the ASX the COH exact significance... then the penny will drop (or dollars will pop for the sp).
So if you believe in this story... position your RAC exposure apparently... ie. load the truck up. Three prominent biotech investors believes so and approached RAC last week to buy-in $3m of shares. if you don't believe it is significant...stay on the sidelines.
RAC - Charts & Price Action, page-39
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
-0.005(0.40%) |
Mkt cap ! $204.3M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.21 | $120.5K | 97.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 991 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 2409 | 1 |
View Market Depth
| Last trade - 16.10pm 02/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.24 |
Change
-0.005 ( 0.40 %) |
||||
| Open | High | Low | Volume | ||
| $1.24 | $1.25 | $1.21 | 17303 | ||
| Last updated 15.51pm 02/05/2024 ? | |||||
| RAC (ASX) Chart |